Research shows a small group of participants in an Alzheimer’s study experienced a significant delay in the onset of symptoms.

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Recent research suggests lecanemab may be less effective in females, raising important questions for future Alzheimer’s drug ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

Bioenergetic age, or how efficiently cells produce energy, could predict Alzheimer’s risk, with healthy lifestyle choices ...

Researchers have discovered that a person's "bioenergetic age," reflecting how efficiently cells produce energy, strongly predicts Alzheimer's risk and progression.

An appointment with Wendell Helveston, M.D., a neurologist in Hattiesburg, MS, led to a series of diagnostic tests, such as ...

Notably, microglia spatially associated with amyloid plaques exhibited increased expression of TREM2 and ApoE compared to ...

with the companies seeking a green light on the strength of the results of a phase 2b trial ahead of the readout of the confirmatory Clarity AD trial, due in the autumn. If lecanemab is approved ...